S&P 500   4,288.58 (-0.26%)
DOW   33,510.82 (-0.46%)
QQQ   358.24 (+0.06%)
AAPL   171.83 (+0.67%)
MSFT   317.59 (+1.26%)
META   301.92 (-0.67%)
GOOGL   131.31 (-0.76%)
AMZN   127.78 (+1.43%)
TSLA   251.05 (+1.90%)
NVDA   437.03 (+1.42%)
NIO   9.05 (+1.57%)
BABA   86.97 (+1.67%)
AMD   103.50 (+0.72%)
T   15.04 (+0.20%)
F   12.45 (-0.88%)
MU   68.44 (+4.97%)
CGC   0.78 (-3.80%)
GE   110.83 (-1.34%)
DIS   81.30 (+1.46%)
AMC   8.01 (+2.82%)
PFE   33.22 (+3.52%)
PYPL   58.67 (+0.84%)
NFLX   378.60 (+0.60%)
S&P 500   4,288.58 (-0.26%)
DOW   33,510.82 (-0.46%)
QQQ   358.24 (+0.06%)
AAPL   171.83 (+0.67%)
MSFT   317.59 (+1.26%)
META   301.92 (-0.67%)
GOOGL   131.31 (-0.76%)
AMZN   127.78 (+1.43%)
TSLA   251.05 (+1.90%)
NVDA   437.03 (+1.42%)
NIO   9.05 (+1.57%)
BABA   86.97 (+1.67%)
AMD   103.50 (+0.72%)
T   15.04 (+0.20%)
F   12.45 (-0.88%)
MU   68.44 (+4.97%)
CGC   0.78 (-3.80%)
GE   110.83 (-1.34%)
DIS   81.30 (+1.46%)
AMC   8.01 (+2.82%)
PFE   33.22 (+3.52%)
PYPL   58.67 (+0.84%)
NFLX   378.60 (+0.60%)
S&P 500   4,288.58 (-0.26%)
DOW   33,510.82 (-0.46%)
QQQ   358.24 (+0.06%)
AAPL   171.83 (+0.67%)
MSFT   317.59 (+1.26%)
META   301.92 (-0.67%)
GOOGL   131.31 (-0.76%)
AMZN   127.78 (+1.43%)
TSLA   251.05 (+1.90%)
NVDA   437.03 (+1.42%)
NIO   9.05 (+1.57%)
BABA   86.97 (+1.67%)
AMD   103.50 (+0.72%)
T   15.04 (+0.20%)
F   12.45 (-0.88%)
MU   68.44 (+4.97%)
CGC   0.78 (-3.80%)
GE   110.83 (-1.34%)
DIS   81.30 (+1.46%)
AMC   8.01 (+2.82%)
PFE   33.22 (+3.52%)
PYPL   58.67 (+0.84%)
NFLX   378.60 (+0.60%)
S&P 500   4,288.58 (-0.26%)
DOW   33,510.82 (-0.46%)
QQQ   358.24 (+0.06%)
AAPL   171.83 (+0.67%)
MSFT   317.59 (+1.26%)
META   301.92 (-0.67%)
GOOGL   131.31 (-0.76%)
AMZN   127.78 (+1.43%)
TSLA   251.05 (+1.90%)
NVDA   437.03 (+1.42%)
NIO   9.05 (+1.57%)
BABA   86.97 (+1.67%)
AMD   103.50 (+0.72%)
T   15.04 (+0.20%)
F   12.45 (-0.88%)
MU   68.44 (+4.97%)
CGC   0.78 (-3.80%)
GE   110.83 (-1.34%)
DIS   81.30 (+1.46%)
AMC   8.01 (+2.82%)
PFE   33.22 (+3.52%)
PYPL   58.67 (+0.84%)
NFLX   378.60 (+0.60%)
NYSE:MRK

Merck & Co., Inc. (MRK) SEC Filings & 10K Form

$103.07
-1.23 (-1.18%)
(As of 03:52 PM ET)
Compare
Today's Range
$102.71
$104.68
50-Day Range
$103.96
$111.34
52-Week Range
$86.02
$119.65
Volume
3.78 million shs
Average Volume
7.53 million shs
Market Capitalization
$261.54 billion
P/E Ratio
84.48
Dividend Yield
2.83%
Price Target
$124.74

Recent Merck & Co., Inc. SEC Filings

DateFilerForm TypeView
08/03/2023
3:12 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2023
5:46 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
3:53 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:36 PM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:21 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
1:09 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/27/2023
1:10 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/27/2023
1:11 PM
Merck & Co., Inc. (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/31/2023
3:20 PM
LAVIZZO-MOUREY RISA J (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
1:55 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
2:08 PM
Merck & Co., Inc. (Issuer)
Warden Kathy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
2:11 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
1:07 PM
BAKER DOUGLAS M JR (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2023
8:00 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
7:58 PM
Merck & Co., Inc. (Subject)
Form FWP
05/08/2023
7:17 AM
Merck & Co., Inc. (Filer)
Form 424B5
05/05/2023
4:13 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
4:19 PM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2023
6:39 AM
Merck & Co., Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
5:11 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:14 PM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:18 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:22 PM
Merck & Co., Inc. (Issuer)
Williams David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:26 PM
Klobuchar Michael A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:29 PM
Litchfield Caroline (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:33 PM
Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:37 PM
LeCointe-Cephas Lisa (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:47 PM
Downing Cristal N (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:50 PM
Merck & Co., Inc. (Issuer)
Romanelli Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:56 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
5:01 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:34 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:40 PM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:43 PM
Guindo Chirfi (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
3:30 PM
Merck & Co., Inc. (Subject)
Zachary Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
3:08 PM
Karachun Rita A (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2023
3:24 PM
Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
3:28 PM
Merck & Co., Inc. (Subject)
MIZELL STEVEN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/03/2023
3:10 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
2:00 PM
Klobuchar Michael A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2023
2:11 PM
LeCointe-Cephas Lisa (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
10:37 AM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
3:30 PM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/28/2023
4:15 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2023
3:28 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/27/2023
5:43 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2023
3:34 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2023
3:47 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2023
7:58 AM
Merck & Co., Inc. (Subject)
Seventh Generation Interfaith Inc. (Filed by)
Form PX14A6G
04/03/2023
3:51 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2023
3:42 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2023
3:45 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2023
3:06 PM
Merck & Co., Inc. (Filer)
Form DEF 14A
04/03/2023
3:10 PM
Merck & Co., Inc. (Filer)
Form DEFA14A
02/16/2023
10:58 AM
Merck & Co., Inc. (Issuer)
Romanelli Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2023
10:28 AM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2023
9:27 AM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2023
3:21 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2023
5:42 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2023
4:33 PM
Merck & Co., Inc. (Issuer)
Williams David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
4:38 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
4:26 PM
Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
4:14 PM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:59 PM
Li Dean Y (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
4:03 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:52 PM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:56 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:41 PM
Klobuchar Michael A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:48 PM
Litchfield Caroline (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2023
3:35 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2023
3:22 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
3:35 PM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
3:42 PM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2023
3:21 PM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2022
4:01 PM
Merck & Co., Inc. (Issuer)
MIZELL STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2022
3:42 PM
Davis Robert M (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2022
3:44 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:06 PM
FRAZIER KENNETH C (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:09 PM
Merck & Co., Inc. (Issuer)
Oosthuizen Johannes Jacobus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
3:06 PM
FRAZIER KENNETH C (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
4:04 PM
DeLuca Richard R. (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
4:07 PM
Chattopadhyay Sanat (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
3:36 PM
Karachun Rita A (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
3:38 PM
FRAZIER KENNETH C (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2022
3:28 PM
Merck & Co., Inc. (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2022
5:38 AM
Merck & Co., Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2022
10:47 AM
Coe Mary Ellen (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
10:49 AM
GLOCER THOMAS H (Reporting)
Merck & Co., Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
10:50 AM
Merck & Co., Inc. (Issuer)
Seidman Christine E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2022
10:52 AM
Merck & Co., Inc. (Issuer)
WENDELL PETER C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:MRK) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -